Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
暂无分享,去创建一个
R. Lange | I. Barbash | D. Dvir | J. Webb | V. Guetta | A. Colombo | K. Sideris | A. Segev | S. Buccheri | A. Vahanian | R. Makkar | H. Jilaihawi | D. Himbert | C. Tamburino | D. Tchétché | M. Barbanti | A. Latib | S. Bleiziffer | S. Immé | Y. Abramowitz | F. Deuschl | N. Schofer | M. Simonato | H. Treede | Tadashi Miyazaki | R. Makkar | F. Rosa | Javier Molina-Martín de Nicolás | C. Nguyen
[1] J. Ricotta,et al. Graft-free surgical retroperitoneal vascular access as bail-out technique for failed percutaneous approach to transcatheter aortic valve replacement. , 2013, Cardiovascular revascularization medicine : including molecular interventions.
[2] M. Morice,et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications. , 2012, JACC. Cardiovascular interventions.
[3] J. Leipsic,et al. Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[4] M. Morice,et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. , 2011, JACC. Cardiovascular interventions.
[5] L. Lönn,et al. Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation. , 2015, The American journal of cardiology.
[6] J. Bavaria,et al. Factors Associated With Vascular Complications in Patients Undergoing Balloon-Expandable Transfemoral Transcatheter Aortic Valve Replacement via Open Versus Percutaneous Approaches , 2014, Circulation. Cardiovascular interventions.
[7] A. Cribier,et al. Aorto-iliac angiography as a screening tool in selecting patients for transfemoral aortic valve implantation with the Edwards SAPIEN bioprosthesis. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[8] E. Tuzcu,et al. Comparison of multicenter registries and randomized control trials for transcatheter aortic valve replacement (TAVR). , 2013, Indian heart journal.
[9] J. Leipsic,et al. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. , 2012, Journal of the American College of Cardiology.
[10] Nikhil Kansal,et al. A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial). , 2014, Journal of vascular surgery.
[11] D. Hildick-Smith,et al. Large calibre arterial access device closure for percutaneous aortic valve interventions: Use of the prostar system in 118 cases , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[12] N. Moat,et al. Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry. , 2014, Journal of interventional cardiology.
[13] J. Hausleiter,et al. COMPARISON OF TWO SUTURE MEDIATED CLOSURE DEVICES FOR ACCESS SITE CLOSURE AFTER TRANSFEMORAL AORTIC VALVE IMPLANTATION , 2015 .
[14] M. Mack,et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). , 2014, Journal of the American College of Cardiology.
[15] M. Mack,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[16] A. Diegeler,et al. Simple, effective and safe vascular access site closure with the double‐ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[17] M. Mack,et al. Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy , 2015, Circulation.
[18] S. Haulon,et al. A systematic literature review of the efficacy and safety of the Prostar XL device for the closure of large femoral arterial access sites in patients undergoing percutaneous endovascular aortic procedures. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[19] E. Tuzcu,et al. Predicting vascular complications during transfemoral transcatheter aortic valve replacement using computed tomography: A novel area‐based index , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[20] C. Caussin,et al. Incidence, predictors and prognostic value of serious hemorrhagic complications following transcatheter aortic valve implantation. , 2013, International journal of cardiology.
[21] R J Little,et al. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. , 2000, Annual review of public health.
[22] J. Bavaria,et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. , 2012, Journal of the American College of Cardiology.
[23] C. Stefanadis,et al. Predictive factors of vascular complications after transcatheter aortic valve implantation in patients treated with a default percutaneous strategy. , 2013, Cardiovascular therapeutics.
[24] M. Mack,et al. Propensity-Matched Comparisons of Clinical Outcomes after Transapical or Transfemoral TAVR: A PARTNER-I Trial Substudy , 2015 .
[25] Pascal Vranckx,et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.
[26] P. Leprince,et al. Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.
[27] Susheel Kodali,et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. , 2012, Journal of the American College of Cardiology.
[28] P. Wenaweser,et al. Transcatheter aortic valve implantation and bleeding: incidence, predictors and prognosis , 2013, Journal of Thrombosis and Thrombolysis.